Cargando…
A randomized placebo-controlled PET study of ketamine´s effect on serotonin(1B) receptor binding in patients with SSRI-resistant depression
The glutamate N-methyl-d-aspartate receptor antagonist ketamine has a rapid antidepressant effect. Despite large research efforts, ketamine’s mechanism of action in major depressive disorder (MDD) has still not been determined. In rodents, the antidepressant properties of ketamine were found to be d...
Autores principales: | Tiger, Mikael, Veldman, Emma R., Ekman, Carl-Johan, Halldin, Christer, Svenningsson, Per, Lundberg, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261801/ https://www.ncbi.nlm.nih.gov/pubmed/32475989 http://dx.doi.org/10.1038/s41398-020-0844-4 |
Ejemplares similares
-
Plasma Levels of Brain-Derived Neurotrophic Factor and S100B in Relation to Antidepressant Response to Ketamine
por: Jiang, Haitang, et al.
Publicado: (2021) -
Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder
por: Lundberg, Johan, et al.
Publicado: (2012) -
In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study
por: Svensson, Jonas E., et al.
Publicado: (2022) -
Serotonin 1B receptor density mapping of the human brainstem using
positron emission tomography and autoradiography
por: Veldman, Emma R, et al.
Publicado: (2021) -
Associations Between Cognition and Serotonin 1B Receptor Availability in Healthy Volunteers: A [(11)C]AZ10419369 Positron Emission Tomography Study
por: Tangen, Ämma, et al.
Publicado: (2022)